Acute Coronary Syndrome clinical trials at UCSF

1 in progress, 0 open to eligible people

Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Sorry, not currently recruiting here
This is a placebo-controlled, randomized, double-blind, parallel group, phase 3 multicenter study in subjects recently hospitalized for ACS and with the appropriate genetic profile. Subjects will provide informed consent before any study-specific…
San Francisco, California and other locations

Last updated: April 22, 2025